Home Care Operations

Biofourmis monitors patients at home and tries to detect deterioration before it becomes an admission. The Biovitals analytics engine ingests continuous signals from clinical grade wearables, builds a personalised physiological baseline for the individual rather than comparing them to a population norm, and raises an alert when that person drifts from their own pattern. Biofourmis Care wraps that in a care at home offering for hospitals, health systems and payers spanning acute, post acute and chronic acuity, combining the algorithms with devices, in home service orchestration and virtual clinical teams. Biofourmis Connect applies the same monitoring apparatus to decentralised clinical trials for biopharma customers. BiovitalsHF, a heart failure product aimed at optimising medication dosing, received Breakthrough Device Designation in 2021. The corporate history is turbulent and a reader should have it. Founded in 2015 and originally based in Singapore, the company moved its headquarters to the United States in 2019 with about 60 employees and grew to roughly 650 including two acquisitions. It raised in the region of 460 million dollars across six rounds, including 100 million in 2020 and a 300 million dollar round in 2022 that valued it at 1.3 billion, backed by SoftBank Vision Fund, General Atlantic, Openspace, Bessemer Venture Partners, Intel Capital and CVS Health. In July 2023 it cut 120 roles globally, about 15 percent of the company, and the founding chief executive stepped down a month later. In October 2024 it merged with CopilotIQ, a Nashville company running high frequency connected care for older adults with hypertension and diabetes using continuous biomarker data, behavioural analytics and nursing visits by licensed clinicians. The transaction was all stock, existing investors put close to 100 million dollars into the combined business, and CopilotIQ's chief executive David Koretz leads the combined entity. Biofourmis continues to be sold under its own name with its own product lines, so the change of control does not alter how this record reads. Named customers include UCI Health, Lee Health, Community Health Network, Augusta University Health under a four year collaboration, and Orlando Health under a multi year agreement. A partnership with GE HealthCare announced in February 2024 was intended to extend that manufacturer's patient monitoring reach from the hospital into the home. Headquartered in Needham, Massachusetts. Two things a reader should weigh. A dedicated pass located no company announcement of any kind after the October 2024 merger, and the corporate website, while live and carrying a current copyright, still displays placeholder Latin text in its main navigation menus. Neither fact establishes anything about the health of the business, and both are things a buyer would want to ask about directly. And no pricing of any kind was located.

Nanowear weaves the sensors into the clothing. SimpleSense is a gender neutral, size adjustable undergarment built from patented cloth based nanosensors, capturing electrophysiological, hemodynamic, acoustic, metabolic and activity signals simultaneously and time synchronously, and feeding a deep learning platform that turns them into diagnostics. The company describes capturing more than 100 million data points per patient per day across cardiac, pulmonary and circulatory biomarkers, and positions the garment as replacing several separate instruments a clinician would otherwise use in sequence. Regulatory standing is the strongest element and includes one clearance type that matters more than its number. Four United States clearances span 2016, 2020, 2021 and January 2024. The 2021 clearance was software only, establishing standalone artificial intelligence and deep learning algorithms as a medical device in their own right rather than as an accessory to hardware. The 2024 clearance covered a cuffless continuous blood pressure diagnostic built on a four decision tree algorithmic model, validated across three study arms with training and validation performed in independent geographies and in demographic populations described as mirroring the most recent national census. The company publishes its indication for use, which is rare enough in this index to be worth stating plainly, and a reader should compare it against the marketing. The published indication covers use at home or in a healthcare facility, under the direction of a licensed medical professional, to record, display and store two leads of electrocardiogram, respiration rate measured through thoracic impedance, heart sounds, and activity including posture. That is a narrower and more precise claim than a garment capturing 85 or more biomarkers and replacing a stethoscope, a Holter monitor, a capnograph and a blood pressure cuff. Both statements come from the company; the cleared one is the one that binds. A dedicated security page exists naming Amazon Web Services as the host and linking a privacy notice, which again is more than most vendors here provide. Founded in 2014 and headquartered in New York with research operations in Berkeley and University Park, led by co founder and chief executive Venk Varadan. Intellectual property spans 13 awarded and 12 pending patents covering the nanotechnology, sensor manufacturing, the wearable, the software platform, the ingestion pipeline and the algorithms. Reported funding totals vary widely across sources and the chief executive has publicly stepped back from pursuing venture capital, so no figure is asserted here. Recent activity includes a licensing and data partnership ingesting continuous glucose readings from Dexcom and an integration initiative with blood collection patches. No pricing of any kind was located.

Aloe Care Health rebuilt the medical alert pendant around voice and sensors. Its patented Smart Hub sits in the home carrying motion, temperature and air quality sensors, connects over cellular without requiring home broadband, and can be triggered three ways: a large central button that doubles as a motion activated nightlight, a wearable care button, or simply saying the word emergency aloud. Yes and no buttons let an older adult answer an operator or a family member without finding a phone. A Mobile Companion extends coverage outside the home with fall detection, location and caregiver speed dial, and a caregiver application connects an unlimited circle of family members. Behind it sits a professional emergency response centre available at all hours. The design choices are deliberate and worth naming. There are no cameras, which the company states plainly as a differentiator in a category increasingly built on them. Connectivity is cellular first with battery backup, addressing the failure mode where an older adult's router quietly stops working. Fall detection sensitivity is user adjustable. And the fall detection claim carries an explicit published caveat that it cannot detect every fall, printed beside the feature rather than buried, which is a candour almost nothing else in this index matches on a safety critical function. Monitoring extends past emergencies into ambient wellbeing. The hub watches for unusual movement patterns, inactivity, dangerous air quality, temperature extremes and power outages, notifying caregivers and emergency personnel automatically when something is out of the ordinary. Commercially it is unusually legible because it is a consumer product. Subscriptions are published from around 40 dollars per month across named tiers covering the hub alone, the hub with mobile coverage, and a full package, with a separate one time hardware cost. Roughly 12.1 million dollars was raised across two rounds in 2020 and 2021. In April 2026 Arlo Technologies completed its acquisition of the company, folding the platform into its own subscription services business and describing it as an artificial intelligence powered medical alert and fall prevention platform. The brand and product line continue under their own name, which is why this is indexed separately, though a reader should note that the artificial intelligence framing is considerably stronger in the acquirer's announcement than in the product's own description, which emphasises voice activation, sensors and staffed emergency response. A dedicated pass located no clinical study, no security attestation and no data handling statement.

Electronic Caregiver puts an animated character in an older adult's living room and asks it to do the work a care visit would. Addison Care is a three dimensional avatar running on a tablet, combining conversational speech with real time vitals capture from connected devices, medication management, cognitive engagement exercises, emergency response and escalation into the company's own telecare operation. The avatar is the deliberate design choice: the company spent years arguing that a face and a conversation drive adherence in a way a voice assistant or a portal does not. The underlying stack is described in unusual breadth, spanning augmented reality interfaces, conversational speech, machine learning, visual sensing, biomechanical analytics developed with a state university's health and aging laboratories, record system integration and the connected hardware itself. Large language model integration is explicit, with the platform stated to be integrated with OpenAI's ChatGPT, which is a base model disclosure almost no vendor in this index provides. The commercial position rests on reimbursement rather than on a licence fee. Addison Care launched in June 2025 shipping to Medicare patients under established remote patient monitoring and chronic care management codes, beginning with four clinical locations and a large Alaskan primary care group serving rural patients hours from emergency care. Other routes include a New Mexico developmental disability waiver programme for remote support technology, Medicaid, commercial cover and private pay, alongside national payer taxonomy approvals. More than 100 pilot deployments are claimed across multiple verticals, and a home care franchise partnership markets a hybrid model combining in person visits with continuous virtual care. The company is not only software. It operates a full telecare function with nursing and clinical support, round the clock emergency response, physician on demand, national device fulfilment and device lifecycle management. Its own chief executive frames that operational depth rather than the artificial intelligence as the real barrier to entry, which is an honest description of what the business is. Based in Las Cruces, New Mexico, previously trading as SameDay Security, led by founder Anthony Dohrmann. Roughly 42.5 million dollars was raised in a round with a warrant exercise, following 35 million dollars in private equity in 2019. Outcome figures circulate in partner directories, including a 47 percent readmission reduction and a 70 percent expansion of inpatient capacity through hospital at home, with no method, sample or site attached. No pricing, security attestation or trust centre was located.

Vivalink sells the sensing and data layer that other companies build monitoring products on. Its Biometrics Data Platform combines medical grade reusable wearables with edge networking, cloud data services and a development kit, so a digital health company, a hospital at home programme or a clinical trial sponsor can capture continuous physiology without building the hardware or the pipeline. Sensors cover a multi function cardiac electrocardiography patch, a clinical temperature monitor, oxygen saturation and blood pressure, and the platform additionally ingests third party devices including glucose monitors and pulse oximeters from established manufacturers. The technical lineage is genuine. The company introduced a breathable thin film substrate with integrated circuits and sensors in 2014, developed in collaboration with Google's advanced technology group and launched commercially as a digital tattoo, and that substrate underpins the current sensor family. Regulatory and standards posture is the strongest part of this record and is enumerated rather than gestured at. Sensors carry clearance in the United States, the European Union and China. The platform is stated to comply with United States health privacy law, European data protection law, the federal rule governing electronic records and signatures in regulated research, and a stack of device standards covering quality management, medical device software lifecycle, risk management and biocompatibility, alongside the international information security management standard. Very few vendors in this index name an information security certification at all, and fewer still list the software lifecycle and biocompatibility standards that a skin adhering connected device actually needs. The business is enablement rather than end user software. More than 400 customers are claimed with brand reach across 116 countries, and named applications include ambulatory cardiac monitoring, hospital at home and decentralised clinical trials, with a partnership placing the technology inside a global trial infrastructure provider. Research use includes a longitudinal atrial fibrillation study of up to 3,000 subjects, a chronic obstructive pulmonary disease progression study, and sleep research. Founded in 2014 by Jiang Li and based in Campbell, California, operating as VivaLNK, Inc. Funding is poorly documented in public sources and the figures that circulate appear inconsistent with the company's stated commercial reach, so no total is asserted here. Two things a reader should weigh. This is closer to infrastructure than most records in this index, since much of the value is capturing and delivering data rather than interpreting it, and the clinical application is frequently the customer's. And no pricing of any kind was located.

Current Health enables hospital at home. Its platform combines a continuous vital signs wearable with aggregated data from other remote monitoring devices and patient reported information, presenting a picture of a patient's trajectory to a clinical team that is not in the room. Around that sits the operational machinery that makes acute care at home actually work: device kits, in home installation, patient onboarding, virtual visits and care coordination. Oncology at home is addressed as a distinct programme alongside general acute and chronic care. The wearable received United States Class II clearance in February 2019 as an artificial intelligence powered device, monitoring vital signs continuously and delivering patient specific alerts, with further machine learning related clearance reported in 2021. The company was founded in 2014 in Edinburgh by Christopher McGhee after watching his grandmother manage chronic obstructive pulmonary disease, dementia and congestive heart failure at home, and is now headquartered in Boston. Deployment reach is the strongest fact on this record. The company states that more than one third of all patients in the United States who have had a hospital at home experience were cared for through its platform, with more than 70,000 patients across care models. Named health system partners include Mass General Brigham, Geisinger, UC Davis, Atrium Health, Baptist Health, UMass Memorial Health, Virtua Health and OSF HealthCare. A partnership with Cardinal Health's Velocare handles last mile fulfilment, installation and retrieval of in home monitoring kits. Ownership has moved twice and a reader should understand both moves. Best Buy acquired the company in October 2021 for 400 million dollars and sold it back to founder Christopher McGhee in June 2025, exiting care at home entirely and recording 109 million dollars of restructuring charges followed by a further 192 million dollar impairment as it wound down remaining health system relationships. The company is independent again under its original founder. The reason for that exit is the most important commercial fact in this record and it is not about the technology. Acute hospital at home in the United States is paid for through a federal waiver whose renewal has repeatedly been caught in budget negotiations, and that uncertainty was cited directly by the acquirer as why adoption scaled more slowly than expected. Roughly 400 hospitals across 142 systems in 30 states were approved under the waiver as of mid 2025, against 20 programmes before it existed. Any buyer evaluating this category is underwriting a reimbursement policy as much as a product. Two dedicated passes located no pricing, no security attestation, no data handling statement and no peer reviewed outcome study.

Vayyar Care detects falls and monitors movement using 4D imaging radar, with no camera and nothing worn. A ceiling or wall mounted sensor builds a point cloud of the room and machine learning classifies what is in it: falls both major and minor, room presence, mobility, time at rest and bathroom visits. Low power radio waves pass through obstructions, so the sensor keeps working through shower curtains and steam and in any lighting, which means the bathroom, the room where falls are most likely and cameras least acceptable, is covered by a modality that cannot produce an image. This record covers the product, not the company. Vayyar Imaging is a semiconductor business whose radar on chip platform serves automotive, smart home, retail, robotics, public safety and radio frequency testing alongside senior care, and as a whole it fails the horizontal test this index applies. Vayyar Care is a distinct product line with its own integrations, its own regulatory compliance and its own named deployments, and it is indexed here on the same basis that a diagnostic product line was separated from its parent elsewhere in this index. The technical disclosure is better than the lane norm in two specific ways. The underlying chip is specified publicly, covering imaging and radar bands from 3 to 81 gigahertz with up to 72 transceivers and an integrated digital signal processor. And coverage is published as a number rather than a claim: 13 feet to the front and 6 feet 6 inches to either side, with an explicit statement that large rooms may require more than one device. A vendor that publishes the limit of its own sensor, and says plainly when one will not be enough, has disclosed something that costs it. Distribution runs through the systems care staff already use. Named production integrations include TekTone Tek-CARE and Austco Tacera nurse call platforms, K4Connect K4Community, TLS Evolve and SenSights.AI, with the company stating interoperability with any nurse call system and care platform. Austco alone carries it across Australia, the United Kingdom, Canada and the United States. A consumer route exists through an Amazon subscription integration, and because that depends on a third party service a buyer should confirm current availability. Field deployment is real and multinational. Essex County Council reported eliminating hospital admissions and long lies from one of the largest single installations of this technology in January 2026, a United Kingdom care home published a resident safety case study in April 2026, and an Ontario long term care provider piloted 122 units. A partnership with TLS dating to 2018 is described as having detected hundreds of real falls. Two regulatory facts are stated and worth carrying. The device is described as fully approved by the United States communications regulator, which is the spectrum authorisation an emitting device in a dwelling requires, and the platform achieved the DCB0129 clinical safety standard in January 2026, the United Kingdom clinical risk management standard for health technology manufacturers. Vayyar Care makes no vital signs claim, which keeps it clear of the device boundary that other radar vendors in this lane approach. Vayyar Imaging was founded in 2011 by Raviv Melamed, Miri Ratner and Naftali Chayat, originally to detect early stage breast cancer using radio frequency, and has raised more than 300 million dollars including a 108 million dollar Series E in 2022 led by Koch Disruptive Technologies. Reporting in 2024 described layoffs and a narrowing of focus to smart home and automotive; the senior care line has continued shipping, integrating and certifying through 2026 regardless, and a buyer should read those two facts together rather than either alone.

Cherish Health detects falls and vital signs by bouncing radar off people, with no camera and nothing worn. Cherish Serenity is a device shaped like an old transistor radio that sits in the corner of a room and senses through walls, covering multiple rooms and multiple people from a single unit. Cherish AI runs at the edge, on the device itself, classifying what the radar returns into body position, movement, falls, heart rate and respiration. The discrimination problem is the interesting part of the engineering. A person lowering themselves to the floor deliberately and a person falling produce similar endpoints, and the company states its models separate them by reading body position through the descent. It also claims to catch the harder case, a fall where someone grabbed a table on the way down, which an accelerometer in a wearable would miss because the deceleration never happens. The most aggressive sensing claim is that heart rate and respiration can be read from 40 feet away through two walls with nothing worn, described by the chief executive as demonstrated in the company's own laboratory rather than published. The privacy argument is the commercial argument. Radar produces no image, so nothing resembling video of a person in a bedroom or bathroom ever exists, and edge inference means classification happens on the device. Industry coverage of the category notes that older adults are frequently unwilling to accept in home cameras, and this product is positioned directly at that refusal. Distribution runs through partners rather than a direct sales force. AT&T supplies cellular connectivity as the default, with first responder network capability, Alarm.com carries the Serenity Enterprise Hub to its service provider network for facility deployments, and security dealers including ADT sell and install to consumers. A partnership with Health eVillages placed devices at a Massachusetts veterans centre, and a senior care offering with Aileen was announced at HIMSS in March 2026. Founded in 2020 by Sumit Nagpal and Mike Sutcliff and based in Boston. Roughly 26 million dollars was raised in a Series A in March 2024 from angel and undisclosed investors, notable because the company has publicly stated it took no venture capital, and a larger second round was reported as planned. Cherish Serenity launched at CES in January 2024 and won a Fast Company Innovation by Design award that year. Two cautions for a reader. Consumer pricing of roughly 250 to 300 dollars for the device plus 39 dollars monthly comes from press reporting at launch rather than a published rate card, and dealer distribution means the price a buyer actually pays may differ. Separately, several third party company databases carry materially wrong information about this company, including an incorrect founding year, a competitor set drawn from robotic exoskeletons, and in one case an assertion that the company is publicly listed on a foreign exchange. None of it informed this record.

CarePredict infers what an older adult is doing from how their wrist moves, and raises an alert when the pattern changes. The Tempo wearable carries a motion sensor for gesture recognition alongside heart rate and pulse oximetry, and machine learning classifies activities of daily living from it: eating, drinking, bathing, grooming, tooth brushing, toilet use, walking, sitting and sleeping. Peel and stick Context beacons add room level indoor location, so the system knows not only that someone is washing but where. The models take roughly seven days to learn an individual's normal pattern, after which deviation from that personal baseline is the signal. The headline claims are early detection ones. The company states it can surface a urinary tract infection up to 3.7 days before clinical diagnosis and depression around two weeks ahead, by reading changes such as reduced eating, increased bathroom use or decreased mobility. Falls, malnutrition and elopement risk are addressed by the same behavioural layer. A substantial part of what is deployed is not predictive at all. Tempo also serves as a resident call device with two way voice, fall detection, wander management, real time location and keyless door entry by radio frequency identification, and integrators describe the system as a next generation emergency call platform. A PinPoint tool uses retained location history for contact tracing, and a TouchPoint application gives family members a real time view of a relative's activity. Vital signs are captured from separate third party cleared devices and uploaded to the dashboard or a record system, so the accuracy of those readings belongs to those devices rather than to CarePredict. Buyers are senior living operators across assisted living, memory care and independent living, home care agencies, and families buying directly for a relative aging in place. Named communities include Grand Retirement, Spring Creek Enterprise, SRI Management, Tradition Senior Living and Bickford Senior Living. Distribution extends to Canada through a reseller. Founded by Satish Movva and based in Fort Lauderdale, Florida. A 9.5 million dollar round was reported in 2019 and no subsequent raise was located, though the storefront, the reseller channel and a hardware partner case study dated December 2025 all indicate continuing operation. The Tempo wearable itself is built by NEXA Mobility, which is named publicly as the hardware partner. Pricing is more open than almost anything else in this index. The direct storefront publishes 69.99 dollars per month for the consumer at home subscription with a 45 day trial and no annual contract, and the Canadian reseller lists a two person annual package at 138 dollars per month. Enterprise senior living pricing, including the beacon infrastructure a building requires, is not published anywhere. Two cautions for a reader. Marketing carried on distributor pages states fall reduction of 69 percent and length of stay increase of 67 percent with no method, sample or citation attached, and those figures should be treated as unsupported until sourced. Separately, several third party company profiles of CarePredict circulating online contain precise sounding operational statistics that trace to no primary source and appear to be machine generated; none of them informed this record.

End to end cloud platform for home and community based care, spanning needs assessment, care planning, clinical documentation, scheduling and route optimisation, visit verification, billing, family portals, remote patient monitoring, telehealth and mobile care worker applications. Founded 2014 by Adrian Schauer, who won a national entrepreneur award in 2025. Roughly 608 staff as of February 2026. Sources disagree on headquarters, giving Toronto and Montreal, with a United States entity registered in Boston. Market coverage is unusually specific and genuinely international. The platform is sold across Canada, the United States and Australia, into private duty nursing and non skilled care, Medicaid, community support services, therapy, patient support programmes, clinical pharmacy, hospice, home infusion, and Australian aged care including consumer directed care and the national disability scheme. That last is a country specific programme rather than a generic claim to international availability. The artificial intelligence sits on top of the platform rather than being it. A dedicated research group develops the capability, which covers predictive analytics flagging clients at risk before escalation, clinical documentation extraction, travel time reduction, an employee retention dashboard, and back office automation. Two named products carry it: Layla, an assistant launched in Canada in June 2025, and AlayaFlow, agentic workflow automation launched in October 2025. The company claims agencies reclaim 80 percent of time and costs through the newer automation, a figure published in March 2026 and unsupported by any study located. Trust posture is stronger than most records in this index. A trust centre exists as a named destination, the platform is stated to meet four named privacy frameworks across two countries and to pass regular controls audits at the more demanding report type, with the original certification audited by a named accounting firm in 2020. Infrastructure runs on a named public cloud with data sovereignty cited as a design consideration across the three markets. The finding worth flagging is on governance. The company publicly references its signatory status under a national voluntary code of conduct for advanced generative artificial intelligence systems, which is the first verifiable artificial intelligence governance credential recorded anywhere in this index. It is a commitment framework rather than published evidence, and it is more than any competitor offers. No pricing is published by the vendor. Third party software directories estimate entry cost around 1,000 dollars per month scaling with practitioner count, modules, integrations and training, and one explicitly rates the company's pricing transparency as low. Those are estimates rather than disclosure and are recorded as such. Named customers include CBI Home Health, which renewed nationally in June 2025, and a group of 33 community support agencies modernised in August 2025. Financing includes a 50 million dollar growth capital facility from a Canadian bank in February 2026.

IntelyCare matches nurses and nursing assistants to open shifts, and the machine learning does two jobs rather than one: it optimises the match and it optimises the price. Facilities pay a flat rate for the platform, and the wage offered for a given shift is set according to how easy or hard that shift is to fill. Founded in 2016 near Boston by David Coppins, Ike Nnah and Chris Caulfield, and based in Quincy, Massachusetts, it has raised roughly 174 million dollars. A 45 million dollar Series B in 2020 drew Endeavour Vision, Kaiser Permanente Ventures and Generator Ventures; a 115 million dollar Series C in April 2022 led by Janus Henderson took the valuation above 1.1 billion dollars. Coppins moved from chief executive to executive chairman, and Matthew Levesque now leads the company. In January 2026 it acquired CareRev, the on demand workforce platform for acute care, with both brands continuing to operate. That took the company from its post acute origins into hospitals and produced a combined offering spanning permanent staff, internal resource pools and contingent labour in one system. Anyone searching for CareRev is looking at this group. The employment model is a deliberate counter position in a market of gig platforms. Nurses on the platform, called IntelyPros, are employed as W2 workers with health, retirement and education benefits, which the company frames as giving the flexibility of gig work without the instability of traditional agency work. The technology learns from every interaction, taking in nurse and facility preferences and a two way rating system to improve matching over time, and the company states it creates shifts before facilities recognise their own need. Hours are validated by geofencing when a nurse checks in and out through the mobile application. Reported performance is a fill rate around three times the industry average, which the company describes as the highest in the market.

Element5 automates the back office of post acute care: home health, hospice, skilled nursing and senior living. It is based in San Jose with a second headquarters in Chennai, was co founded around 2020 by chief executive Joe Randesi and chief revenue officer Eric Gordon among others, and has raised 48.5 million dollars, with both a 15 million dollar Series A in 2021 and a 30 million dollar Series B in 2022 led by Insight Partners. The origin is robotic process automation. The company's own early description was of trained robots that log into everyday systems and perform administrative tasks exactly as a person would, saving teams hours of repetitive clicks. That heritage matters when reading the current product, because another vendor in this index builds its whole architectural argument against precisely this approach, on the ground that recorded screen interactions break whenever a payer changes a portal. The platform has since moved toward agentic automation under the name Neos, described as a modular end to end solution spanning the patient financial journey, with eligibility and authorisation handled across a connected network. The workflow list is specific and long: insurance eligibility verification at admission and during episodes, authorisation processing including polling convenor portals for status changes, hospice benefit period verification, denial categorisation with prioritisation of high value cases, claims submission, cash posting, notice of admission and notice of election filing, physician order exchange, and the transition of assessment data into the federal reporting system. The company positions itself as a bridge between record systems, payers, convenors and clearinghouses, and offers building blocks so customers can deploy their own agents for unusual payer or local workflows. Distribution includes a partnership with Homecare Homebase, the post acute record system that states it serves around 37 percent of United States home health and hospice providers. Named customers in published case studies include VNA Health Group, VIA Health Partners, Vivie and Buckeye Home Health. The company was named to the CB Insights Digital Health 150.

Medalogix builds predictive models for home health and hospice and nothing else. Based in Nashville and founded around 2014, led by president and chief executive Elliott Wood, it is described in trade coverage as the only data science company focused entirely on this sector. It absorbed the hospice analytics firm Muse Healthcare in a merger, and Muse now trades as a Medalogix product rather than independently. Three products sit on the same approach. Care predicts hospitalisation risk in home health and recommends a plan built from the histories of similar patients. Pulse, launched in 2022, works visit by visit, drawing on assessment data, vital signs, medications and clinician narrative notes to show how a patient's risk is moving after each contact; the company reports it draws on more than 11 million home health visits and performs over 300 billion calculations. Muse addresses hospice, comparing more than 800 data points for a patient against millions of records to identify when someone is entering their final days. What Muse predicts is death. The company and its customers state precision above 90 percent for identifying a patient within seven days of dying, and the purpose is to send more people rather than fewer: agencies use the prediction to raise visit frequency from nurses and social workers at the end of life, with customers reporting as many as 82 percent more visits than the national average during that period. Reported outcomes elsewhere are operational. The home health product is associated with a near 20 percent reduction in hospitalisation and 2.4 fewer visits per episode, and a separate partner reports an 8.2 percent reduction in unwanted hospital transfers. Distribution runs through the sector's dominant record systems rather than direct. Homecare Homebase, which states it serves around 37 percent of United States home health and hospice providers, is an exclusive partner for the hospice product, and the models also surface inside the MatrixCare workflow. Enterprise customers include Amedisys, Enhabit and AccentCare.

Audio based AI monitoring for home care and senior living, and the third distinct sensing architecture in this lane. Small audio pods placed through a residence listen for verbal and non verbal cues rather than using cameras, a deliberate choice the founder attributes to cameras feeling intrusive in the home. The Care Agent continuously detects and predicts care events across physical, cognitive, and emotional wellbeing, and the company reports identifying more than 100 distinct insights, extending well past emergencies: alongside falls it flags possible urinary tract infections, pneumonia, early signs of cognitive decline, and softer signals including changes in activity level, sentiment, and lack of companionship. A clinical team including a social worker, occupational therapist, nurses, and geriatrics clinicians develops new data points on an ongoing basis. The platform has expanded beyond monitoring into agency operations with a Growth Agent handling inbound demand and an Ops Agent covering scheduling, callouts, and communication. The company reports serving 80 percent of the largest home care networks in North America and revenue tripling year over year for three consecutive years. Founded 2019 by Romi Gubes; $45 million Series C in October 2025 led by Qumra Capital brought total funding above $98 million.

AI fall detection and prevention for senior living, with a center of gravity in memory care. Wall mounted devices in resident rooms use computer vision to detect falls in real time and alert staff, capturing a short event based video rather than a continuous livestream, so care teams can review what actually happened and address root cause. The company cites that 95 percent of falls are unwitnessed and that residents with cognitive impairment often cannot recount them, which is the specific gap the video review closes: at one operator the system identified nearly 200 silent falls where a resident self recovered and never reported it. The platform spans Safety AI for detection, Guardian hardware including sensors, pendants, and buttons, Discover as the staff web portal, Insight for clinical consultation, and Halo, launched 2025, which merges detection with next generation emergency call and adds virtual check ins, ambient care tracking, and staffing analytics. Reported reach is more than 800 communities over seven years. Note the architectural contrast with Inspiren, also indexed here: SafelyYou uses cameras with event based capture, while Inspiren uses camera free skeletal imaging. Both address the same problem with materially different privacy tradeoffs. More than $70 million raised across Series A and B, with early NIA Small Business Innovation Research grants totaling over $2.8 million.

AI care platform for senior living operators, combining proprietary hardware with software. AUGi is a discreet wall mounted device that monitors resident rooms without cameras, using skeletal imaging the company calls geometric exoskeletal monitoring to detect falls, identify hazards, and track movement and behavior patterns while preserving privacy. AUGi Call adds an emergency call system with two way voice and privacy protected live visual context for triage. Inspiren HQ aggregates the device data into clinical and operational dashboards covering care level accuracy, staffing, and incident replay. The company reports that data driven care level accuracy has recovered up to 30 percent of revenue otherwise missed through under assessed care levels, and a ten month study with Solera Senior Living at its Lumina Las Vegas memory care community reported a 48 percent reduction in resident falls and a 54 percent drop in hospitalizations. Each community is assigned a dedicated clinical specialist. Raised a $35 million Series A led by Avenir.

Home care technology and operations platform for aging care. Honor licenses the Honor Care Platform to independently owned home care agencies (the Honor Care Network) and, since its 2021 acquisition of Home Instead, owns the world's largest home care franchise network. The AI does caregiver to client matching and scheduling: the CEO has stated more than 20 distinct AI algorithms run in the Home Instead network, modeling caregiver motivations across many dimensions to fill shifts and improve retention. This record covers the B2B platform licensed to agencies, not the consumer facing care service.